Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
A USA-based registry for pulmonary arterial hypertension: 1982-2006
T. Thenappan
, S. J. Shah
, S. Rich
, M. Gomberg-Maitland
Medicine - Cardiology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
389
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A USA-based registry for pulmonary arterial hypertension: 1982-2006'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Connective Tissue
100%
Calcium Channel
100%
Survival Rate
50%
Cohort Effect
50%
Epidemiology
50%
Keyphrases
Pulmonary Arterial Hypertension
100%
Connective Tissue Disease
33%
Calcium Channel Blockers
33%
Epidemiology
16%
Pulmonary Hypertension
16%
Etiology
16%
Hypertension Patients
16%
Group by
16%
World Health Organization
16%
Disease-associated
16%
Fatal Infection
16%
Copyright
16%
Survival Rate
16%
Acute Response
16%
Prevalent Cohort
16%
Referral Center
16%
Incident Cohort
16%
Vasodilator Challenge
16%
Tertiary Care Centers
16%
Nursing and Health Professions
Pulmonary Hypertension
100%
Patient Referral
57%
Human Immunodeficiency Virus
28%
Calcium Channel Blocking Agent
28%
Connective Tissue Disease
28%
Survival Rate
14%
Diseases
14%
Epidemiology
14%
World Health Organization
14%
Etiology
14%
Medicine and Dentistry
Pulmonary Hypertension
100%
Patient Referral
57%
Human Immunodeficiency Virus
28%
Connective Tissue Disease
28%
Calcium Channel Blocking Agent
28%
Cohort Effect
14%
Survival Rate
14%
Diseases
14%
Etiology
14%
Biochemistry, Genetics and Molecular Biology
Calcium Channel Blocker
100%
Human Immunodeficiency Virus
100%
Survival Rate
50%
Pharmacology, Toxicology and Pharmaceutical Science
Pulmonary Hypertension
100%
HIV
28%
Calcium Channel Blocker
28%
Connective Tissue Disease
28%
Survival Rate
14%
Diseases
14%
Etiology
14%
Epidemiology
14%